Prediction of Osteoporotic Fractures in Elderly Individuals: A Derivation and Internal Validation Study Using Healthcare Administrative Data.


Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640

Informations de publication

Date de publication:
12 2021
Historique:
revised: 11 07 2021
received: 29 03 2021
accepted: 04 09 2021
pubmed: 8 9 2021
medline: 24 12 2021
entrez: 7 9 2021
Statut: ppublish

Résumé

In Canada and other countries, osteoporosis is monitored as part of chronic disease population surveillance programs. Although fractures are the principal manifestation of osteoporosis, very few algorithms are available to identify individuals at high risk of osteoporotic fractures in current surveillance systems. The objective of this study was to derive and validate predictive models to accurately identify individuals at high risk of osteoporotic fracture using information available in healthcare administrative data. More than 270,000 men and women aged ≥66 years were randomly selected from the Quebec Integrated Chronic Disease Surveillance System. Selected individuals were followed between fiscal years 2006-2007 and 2015-2016. Models were constructed for prediction of hip/femur and major osteoporotic fractures for follow-up periods of 5 and 10 years. A total of 62 potential predictors measurable in healthcare administrative databases were identified. Predictor selection was performed using a manual backward algorithm. The predictive performance of the final models was assessed using measures of discrimination, calibration, and overall performance. Between 20 and 25 predictors were retained in the final prediction models (eg, age, sex, social deprivation index, most of the major and minor risk factors for osteoporosis, diabetes, Parkinson's disease, cognitive impairment, anemia, anxio-depressive disorders). Discrimination of the final models was higher for the prediction of hip/femur fracture than major osteoporotic fracture and higher for prediction for a 5-year than a 10-year period (hip/femur fracture for 5 years: c-index = 0.77; major osteoporotic fracture for 5 years: c-index = 0.71; hip/femur fracture for 10 years: c-index = 0.73; major osteoporotic fracture for 10 years: c-index = 0.68). The predicted probabilities globally agreed with the observed probabilities. In conclusion, the derived models had adequate predictive performance in internal validation. As a final step, these models should be validated in an external cohort and used to develop indicators for surveillance of osteoporosis. © 2021 American Society for Bone and Mineral Research (ASBMR).

Identifiants

pubmed: 34490952
doi: 10.1002/jbmr.4438
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2329-2342

Informations de copyright

© 2021 American Society for Bone and Mineral Research (ASBMR).

Références

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785-795.
Osteoporosis Canada Men and Osteoporosis. 2021. Available from: https://osteoporosis.ca/men-and-osteoporosis/. Accessed September 12, 2021.
Adachi JD, Loannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12(11):903-908.
Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES. Impact of recent fracture on health-related quality of life in postmenopausal women. J Bone Miner Res. 2006;21(6):809-816.
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878-882.
Ioannidis G, Papaioannou A, Hopman WM, et al. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ. 2009;181(5):265-271.
Haentjens P, Magaziner J, Colon-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380-390.
Hopkins RB, Burke N, Von Keyserlingk C, et al. The current economic burden of illness of osteoporosis in Canada. Osteoporos Int. 2016;27:3023-3032.
LeMessurier J, O'Donnell S, Walsh P, McRae L, Bancej C, for the Osteoporosis Surveillance Expert Working Group. The development of national indicators for the surveillance of osteoporosis in Canada. Chronic Dis Inj Can. 2012;32(2):101-107.
European Community Health Indicators Working Group. Indicators for Monitoring Musculoskeletal Problems and Conditions. 2000. Available from: https://ec.europa.eu/health/ph_projects/2000/monitoring/fp_monitoring_2000_frep_01_en.pdf. Accessed September 12, 2021.
Australian Institute of Health and Welfare. National Indicators for Monitoring Osteoarthritis, Rheumatoid Arthritis and Osteoporosis. 2006. https://www.aihw.gov.au/getmedia/ceb67de7-3497-472b-9bbc-50477eac32af/nimorao.pdf. Accessed September 12, 2021.
Jean S, Candas B, Belzile E, et al. Algorithms can be used to identify fragility fracture cases in physician-claims databases. Osteoporos Int. 2012;23(2):483-501.
Beaudoin C, Jean S, Gamache P, Morin S, Brown J, Bessette L. [Osteoporosis Surveillance in Quebec: Prevalence and Incidence ] Surveillance de l'ostéoporose au Québec: prévalence et incidence. Québec: Institut national de santé publique du Québec; 2019.
Public Health Agency of Canada. Canadian Chronic Disease Surveillance System (CCDSS). 2021. https://health-infobase.canada.ca/ccdss/data-tool/. Accessed September 12, 2021.
Reber KC, Konig HH, Becker C, et al. Development of a risk assessment tool for osteoporotic fracture prevention: a claims data approach. Bone. 2018;110:170-176.
Rubin KH, Möller S, Holmberg T, Bliddal M, Søndergaard J, Abrahamsen B. A new fracture risk assessment tool (FREM) based on public health registries. J Bone Miner Res. 2018;33(11):1967-1979.
Yang S, Leslie WD, Morin SN, Lix LM. Administrative healthcare data applied to fracture risk assessment. Osteoporos Int. 2019;30(3):565-571.
Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012;344:e3427.
Moons KG, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1-W73.
Blais C, Jean S, Sirois C, et al. Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach. Chronic Dis Inj Can. 2014;34(4):226-235.
Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013-1022.
Public Health Agency of Canada. Osteoporosis and Related Fractures in Canada: Report from the Canadian Chronic Disease Surveillance System. 2020. Ottawa. https://doi.org/10.24095/hpcdp.41.2.06. Accessed September 12, 2021.
Leslie WD, Morin S, Lix LM, et al. Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int. 2012;23(1):75-85.
Beaudoin C, Moore L, Gagne M, et al. Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression. Osteoporos Int. 2019;30(4):721-740.
Segal JB, Chang H-Y, Du Y, Walston JD, Carlson MC, Varadhan R. Development of a claims-based frailty indicator anchored to a well-established frailty phenotype. Med Care. 2017;55(7):716-722.
Simard M, Sirois C, Candas B. Validation of the combined comorbidity index of Charlson and Elixhauser to predict 30-day mortality across ICD-9 and ICD-10. Med Care. 2018;56(5):441-447.
Ravindrarajah R, Hazra NC, Charlton J, Jackson SHD, Dregan A, Gulliford MC. Incidence and mortality of fractures by frailty level over 80 years of age: cohort study using UK electronic health records. BMJ Open. 2018;8(1):e018836.
Ensrud KE, Ewing SK, Taylor BC, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007;62(7):744-751.
Pampalon R, Hamel D, Gamache P, Raymond G. A deprivation index for health planning in Canada. Chronic Dis Can. 2009;29(4):178-191.
Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267.
Simard M, Dubé M, Gaulin M, Trépanier P-L, Sirois C. [The Prevalence of Multimorbidity in Quebec: Portrait for the Year 2016-2017] La prévalence de la multimorbidité au Québec: portrait pour l'année 2016-2017. 2019. Québec. https://www.inspq.qc.ca/sites/default/files/publications/2577_prevalence_multimorbidite_quebec_2016_2017.pdf. Accessed September 12, 2021.
Dagan N, Cohen-Stavi C, Leventer-Roberts M, Balicer RD. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study. BMJ. 2017;356:i6755.
Sirois C, Ouali A, Simard M. Polypharmacy among older individuals with COPD: trends between 2000 and 2015 in Quebec, Canada. COPD. 2019;16(3-4):234-239.
Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
Balasubramanian A, Zhang J, Chen L, et al. Risk of subsequent fracture after prior fracture among older women. Osteoporos Int. 2019;30(1):79-92.
Beaudoin C, Jean S, Moore L, et al. Number, location, and time since prior fracture as predictors of future fracture in the elderly from the general population. J Bone Miner Res. 2018;33(11):1956-1966.
Therneau T. survConcordance. R Documentation. https://www.rdocumentation.org/packages/survival/versions/3.1-8/topics/survConcordance. Accessed September 12, 2021.
Wolbers M, Blanche P, Koller MT, Witteman JCM, Gerds TA. Concordance for prognostic models with competing risks. Biostatistics. 2014;15(3):526-539.
Hosmer DW, Lemeshow S. Applied Logistic Regression. New-York: Wiley; 1989 p 307.
Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1(1):54-75.
Gerds TA, Andersen PK, Kattan MW. Calibration plots for risk prediction models in the presence of competing risks. Stat Med. 2014;33(18):3191-3203.
Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. New-York: Springer; 2015.
Ogundimu EO, Altman DG, Collins GS. Adequate sample size for developing prediction models is not simply related to events per variable. J Clin Epidemiol. 2016;76:175-182.
Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710-718.
Leslie WD, Lix LM. Comparison between various fracture risk assessment tools. Osteoporos Int. 2014;25(1):1-21.
Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV. Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int. 2007;18(8):1109-1117.
Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006;35(5):293-305.
Kanis JA on behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health-Care Level. Sheffield: University of Sheffield, World Health Organization Collaborating Centre for Metabolic Bone Diseases; 2007.
Johansson H, Kanis JA, Oden A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014;29(1):223-233.
Bessette L, Ste-Marie LG, Jean S, et al. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int. 2008;19(1):79-86.
Warriner AH, Patkar NM, Yun H, Delzell E. Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep. 2011;9(3):122-128.
Leslie WD, Schousboe JT, Morin SN, et al. Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study. Osteoporos Int. 2020;31(6):1059-1067.
Lix LM, Ayles J, Bartholomew S, et al. The Canadian Chronic Disease Surveillance System: a model for collaborative surveillance. Int J Popul Data Sci. 2018;3(3):433.

Auteurs

Claudia Beaudoin (C)

Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Quebec, QC, Canada.
CHU de Québec - Université Laval Research Centre, Quebec, QC, Canada.
Bureau d'information et d'études en santé des populations, Institut national de santé publique du Québec, Quebec, QC, Canada.

Sonia Jean (S)

Bureau d'information et d'études en santé des populations, Institut national de santé publique du Québec, Quebec, QC, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Quebec, QC, Canada.

Lynne Moore (L)

Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Quebec, QC, Canada.
CHU de Québec - Université Laval Research Centre, Quebec, QC, Canada.

Philippe Gamache (P)

Bureau d'information et d'études en santé des populations, Institut national de santé publique du Québec, Quebec, QC, Canada.

Louis Bessette (L)

CHU de Québec - Université Laval Research Centre, Quebec, QC, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Quebec, QC, Canada.

Louis-Georges Ste-Marie (LG)

Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

Jacques P Brown (JP)

CHU de Québec - Université Laval Research Centre, Quebec, QC, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Quebec, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH